We have two R&D centers located in Lianyungang and Shanghai. Our in-house R&D activities span the entire R&D process, including chemical compound design and screening, pharmacological and toxicological studies, CMC, as well as clinical development, which have ensured our high efficiency in developing new drugs. We have national-level research and development designations, including the National Technology Center, Post-doctoral Research Station, and Key National Laboratory, including the National and Local Joint Center for Biopharmaceutical Development, the Academician Workstation of Jiangsu, the Technology Research Center for Gastrointestinal Pharmaceutical in Jiangsu, and established long-term cooperative relationships with a number of domestic research institutes.
Hansoh Pharma has been committed to improving human health through continuous innovation, especially in major disease treatment fields including oncology, CNS, anti-infectives and diabetes.
We have a proven track record of over 20 years of R&D experience. Our dedicated professional R&D team consisted of over 1,200 full-time employees,approximately 400 of whom hold a master’s degree or above. One of them is entitled to special subsidies from the State Council. Other top talents include those who are part of the Jiangsu Program for Entrepreneurial and Innovative Talents and Jiangsu Program for 333 Talents. Our well-structured R&D team ensures the high efficiency of various R&D programs.